<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02005081</url>
  </required_header>
  <id_info>
    <org_study_id>Baxter</org_study_id>
    <nct_id>NCT02005081</nct_id>
  </id_info>
  <brief_title>Baxter: Actifuse SHAPE vs DBX in ACC</brief_title>
  <official_title>A Prospective Study Using Actifuse SHAPE Versus Autograft With Demineralized Bone Matrix to Achieve Bone Fusion in Anterior Cervical Corpectomy (ACC)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wayne State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wayne State University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this single-center, prospective, randomized study is to determine the fusion&#xD;
      rates along with the clinical outcomes of commercially available bone graft substitutes&#xD;
      Actifuse mixed with bone marrow aspirate (BMA) versus autograft mixed with demineralized bone&#xD;
      matrix (DBM), in subjects who require anterior cervical corpectomy (ACC) spinal fusion in&#xD;
      patients experiencing cervical spondylotic myelopathy (CSM).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background Fusion of the spine was introduced in 1911 for the management of deformity and is&#xD;
      currently used to relieve pain and restore function in patients diagnosed with degenerative&#xD;
      disc disease. Degenerative conditions of the spine resulting in functionally limiting back&#xD;
      pain or neck, and arm pain with or without extremity pain and dysfunction are a major problem&#xD;
      in today's world. Recommended treatment for these conditions can vary initially from bed&#xD;
      rest, exercise, traction, manipulation and drug therapy to eventual surgery.&#xD;
&#xD;
      One of the most common neck conditions that occurs among people older than 50 years is&#xD;
      cervical spondylotic myelopathy (CSM). This may produce symptoms of cervical radiculopathy,&#xD;
      myelopathy, or both. Over time, the normal wear-and-tear effects of aging can lead to a&#xD;
      narrowing of the spinal canal. This compresses or squeezes the spinal cord. CSM can cause a&#xD;
      variety of symptoms, including pain, numbness, and weakness. When patients with degenerative&#xD;
      cervical disease require surgery, an anterior decompression of the neural elements and&#xD;
      reconstruction of the anterior column with allograft, bone graft substitutes or autograft is&#xD;
      common. These types of reconstruction surgery can be referred to as Spinal fusion. The&#xD;
      objective of spinal fusion is to eliminate motion of the vertebral body and thereby relieve&#xD;
      pain.&#xD;
&#xD;
      An anterior cervical corpectomy, fusion and instrumentation, is usually performed for&#xD;
      patients who have pressure on their nerves or spinal cord in their neck. This pressure can&#xD;
      lead to pain, weakness or numbness in the arms and occasionally in the legs as well. If&#xD;
      non-operative treatment such as medications and therapy are ineffective, patients may require&#xD;
      surgery in order to relieve the pressure off their spinal cord and nerves.&#xD;
&#xD;
      Anterior cervical corpectomy (ACC) and fusion is performed for patients with symptomatic,&#xD;
      progressive cervical spinal stenosis and myelopathy. It is performed to remove the large,&#xD;
      arthritic osteophytes (bone spurs) that are compressing the spinal cord and spinal nerves.&#xD;
      However, in order to do so generally involves removing nearly the entire vertebral body and&#xD;
      disc, which must be replaced with a piece of bone graft or bone graft substitute and mended&#xD;
      (fused) together to maintain stability.&#xD;
&#xD;
      Neurosurgeons and orthopedic surgeons are performing bone grafting procedures more&#xD;
      frequently. Surgical applications include treating bone defects, fracture fixation, spinal&#xD;
      fusion and in the revision of failed total joint arthroplasties. According to data collected&#xD;
      by the American Academy of Orthopedic Surgeons, more than 500,000 bone graft procedures are&#xD;
      performed annually in the United States.&#xD;
&#xD;
      The most common source of bone graft used to be autograft, the transfer of a small piece of&#xD;
      the patient's own bone from one site, usually the iliac crest, to another. However, the&#xD;
      amount that can be harvested safely is limited; it increases surgery time and may be&#xD;
      complicated by donor site morbidity. The use of allograft, supplying bone graft from other&#xD;
      patients via bone banks, overcomes these difficulties. However, the demand for allograft now&#xD;
      exceeds the supply, there is a small but finite risk of disease transmission, and it is&#xD;
      highly variable in strength. These factors have led to increasing interest in the use of&#xD;
      synthetic bone graft substitutes.&#xD;
&#xD;
      This study will assess the fusion rates along with the clinical outcomes for the use of&#xD;
      Actifuse Synthetic Bone Graft substitutes mixed with bone marrow aspirate and autograft mixed&#xD;
      with demineralized bone matrix in cervical spine fusion. Actifuse is a synthetic, porous,&#xD;
      silicate-substituted hydroxyapatite and has shown that this maximizes a favorable bony&#xD;
      response.&#xD;
&#xD;
      Study Design This randomized study will be conducted prospectively. The clinical and&#xD;
      radiological outcomes of subjects undergoing anterior cervical corpectomy will be documented.&#xD;
      There will be a total of 40 subjects enrolled, 20 in each arm - Actifuse with BMA versus&#xD;
      autograft with DBM. It is anticipated that the study length will be 42 months this is based&#xD;
      on a recruitment period of 18 months followed by a 24 month post-operative follow-up period&#xD;
      for each patient included in the study. Subjects will be randomized 1:1 per arm.&#xD;
      Randomization will be established at the study site by sealed envelopes accessed at the time&#xD;
      of surgery. The sample size of 40 patients will allow statistical comparison between the 2&#xD;
      arms based on a postulated fusion rate of 85 %. Given that this is a single center study with&#xD;
      recruitment over 18 months, the total of 40 subjects is a reasonable goal.&#xD;
&#xD;
      Patient Population Subjects enrolled in this study will be identified from the surgeon's&#xD;
      medical practice and will include subjects who have failed conservative treatment and have&#xD;
      been identified by their own physician as requiring anterior cervical corpectomy, fusion and&#xD;
      instrumentation.&#xD;
&#xD;
      Subjects will be suffering from symptoms with the primary diagnosis of cervical spondylotic&#xD;
      myelopathy or cervical spinal stenosis in one to four contiguous levels between C3 and T1.&#xD;
&#xD;
      Data Collection The clinical site's research coordinator or nurse will complete case report&#xD;
      forms. Data will be collected prospectively, after the patient has agreed to participate in&#xD;
      the study by signing the consent form. Data will be collected from the patient's medical&#xD;
      records, departmental based electronic records and radiographic reports to verify&#xD;
      eligibility. Once the patient is verified eligible for the study, data will be collected from&#xD;
      the same sources above. Information will be captured on case report forms. The patient will&#xD;
      also complete questionnaire forms. The information collected will be used for study analysis&#xD;
      results.&#xD;
&#xD;
      Parameters To Be Assessed Demographics, medical history, X-ray results, quality of life&#xD;
      (SF-36), CT Scan results, Concomitant medications, adverse events, pregnancy test, Body Mass&#xD;
      Index (BMI), Concomitant therapies, diagnosis, comorbidities, fusion rate, visual analogue&#xD;
      scale (VAS) for pain, Neck Disability Index (NDI) Questionnaire, Neurological examination&#xD;
      results, clinical assessments and device malfunction, type and duration of surgery, OR room&#xD;
      time, bone graft details, blood loss, length of hospital stay (LOS),return to work, revision&#xD;
      surgeries and complications.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2013</start_date>
  <primary_completion_date type="Anticipated">October 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Fusion Rates</measure>
    <time_frame>Baseline, 6 weeks, 6 months, 12 months, 24 months</time_frame>
    <description>2 or 4 view x-rays (Lateral, Flexion, Extension, Anteroposterior)at 6 weeks, 6 months, 12 months and 24 months CT scan at 12 months and 24 months Radiographic Fusion Success is defined as evidence of:Bridging trabecular bone on two contiguous segments in two or three planes (axial, sagittal, or coronal),Translational motion less than 3 mm as measured on flexion/extension films,Angular motion less than 3 degrees as measured on flexion/extension films Note: For multi level fusions, all levels must be fused according to the above criteria.&#xD;
Reported at study completion.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Clinical Outcomes</measure>
    <time_frame>Baseline, 6 weeks, 6 months, 12 months and 24 months</time_frame>
    <description>Pain/Function Disability Subjects must exhibit an improvement compared to their preoperative scores in the following measures to be considered a success:Neck Disability Index (NDI),Visual Analogue Scale (VAS),Quality of Life (SF-36v2 - 1 week recall)&#xD;
Reported at study completion.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Clinical Outcomes</measure>
    <time_frame>Baseline, 6 weeks, 6 months, 12 months, 24 months</time_frame>
    <description>Neurological Status Subjects will be considered to be a neurological success if they experience maintenance or improvement of their neurological status when compared to baseline scores.&#xD;
Reported at study completion.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Cervical Spine Degenerative Disease Nos</condition>
  <condition>Cervical Spondylosis With Myelopathy</condition>
  <arm_group>
    <arm_group_label>Actifuse SHAPE</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Actifuse Synthetic Bone Graft substitutes mixed with bone marrow aspirate in cervical spine fusion. Actifuse is a synthetic, porous, silicate-substituted hydroxyapatite and has shown that this maximizes a favorable bony response.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Autograft with Demineralized Bone Matrix</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>autograft mixed with demineralized bone matrix in cervical spine fusion.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Actifuse SHAPE</intervention_name>
    <description>Actifuse Synthetic Bone Graft substitutes mixed with bone marrow aspirate in cervical spine fusion. Actifuse is a synthetic, porous, silicate-substituted hydroxyapatite and has shown that this maximizes a favorable bony response.</description>
    <arm_group_label>Actifuse SHAPE</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Autograft with Demineralized Bone Matrix</intervention_name>
    <description>autograft mixed with demineralized bone matrix in cervical spine fusion.</description>
    <arm_group_label>Autograft with Demineralized Bone Matrix</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  The subject has failed conservative treatment and is a candidate for spinal fusion&#xD;
             surgery.&#xD;
&#xD;
          -  The subject is â‰¥18 years old and of legal age of consent.&#xD;
&#xD;
          -  The subject is, in the investigator's opinion, psychosocially, mentally, and&#xD;
             physically able to fully comply with this protocol, including the post-operative&#xD;
             regimen, attend the required follow-up visits, completion of required forms, and be&#xD;
             able to understand and provide written informed consent.&#xD;
&#xD;
          -  The subject is skeletally mature (epiphyses closed).&#xD;
&#xD;
          -  The subject has voluntarily signed the approved informed consent.&#xD;
&#xD;
          -  The subject is willing and able to participate in post-operative clinical and&#xD;
             radiographic follow up evaluations for 2 years.&#xD;
&#xD;
          -  No previous surgical intervention at the involved fusion level(s);&#xD;
&#xD;
          -  Women of child-bearing potential must not be pregnant or nursing, and agrees to not&#xD;
             get pregnant for 1 year following surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subject has systemic infection or infection at the surgical site.&#xD;
&#xD;
          -  Subject has a medical condition that would interfere with post-operative assessments&#xD;
             and care (i.e., metabolic bone disease, neuromuscular disease, autoimmune disease,&#xD;
             active malignancy, psychiatric disease, paraplegia, quadriplegia, etc.).&#xD;
&#xD;
          -  Subject has a concurrent disease process that would place the subject in excessive&#xD;
             risk to surgery (i.e. significant circulatory or pulmonary problems, or significant&#xD;
             cardiac disease).&#xD;
&#xD;
          -  Subject has a history (present or past) of substance abuse (recreational drugs,&#xD;
             prescription drugs or alcohol) that in the investigator's opinion may interfere with&#xD;
             protocol assessments and/or with the subject's ability to complete the protocol&#xD;
             required follow-up.&#xD;
&#xD;
          -  The subject is pregnant/breastfeeding at the time of enrollment, or plans to become&#xD;
             pregnant during the course of the study.&#xD;
&#xD;
          -  Subject is participating in another clinical study, which could confound results.&#xD;
&#xD;
          -  Subject has ossification of posterior longitudinal ligament (OPLL) at any level&#xD;
&#xD;
          -  History of an osteoporotic fracture of the spine, hip or wrist&#xD;
&#xD;
          -  History of an endocrine or metabolic disorder (e.g., Paget's disease) known to affect&#xD;
             bone and mineral metabolism&#xD;
&#xD;
          -  Taking medications that may interfere with bony/soft tissue healing including chronic&#xD;
             steroid use&#xD;
&#xD;
          -  Known allergy to titanium, stainless steels, polyurethane, polyethylene, or ethylene&#xD;
             oxide residuals&#xD;
&#xD;
          -  Rheumatoid arthritis or other known autoimmune disease or known to have a systemic&#xD;
             disorder such as HIV, active hepatitis B or C or fibromyalgia&#xD;
&#xD;
          -  Severe obesity (Body Mass Index &gt; 40)&#xD;
&#xD;
          -  Physical or mental condition (e.g., psychiatric disorder, senile dementia, Alzheimer's&#xD;
             disease, alcohol or drug addiction) that would interfere with patient self-assessment&#xD;
             of function, pain or quality of life.&#xD;
&#xD;
          -  Involved in current or pending spinal litigation where permanent disability benefits&#xD;
             are being sought&#xD;
&#xD;
          -  Incarcerated at the time of study enrollment&#xD;
&#xD;
          -  Diseases that significantly inhibit bone healing (osteoporosis, metabolic bone&#xD;
             disease, uncontrolled diabetes, dialysis dependent renal failure, symptomatic liver&#xD;
             disease)&#xD;
&#xD;
          -  Undergoing chemotherapy or radiation treatment, or chronic use of steroids (defined as&#xD;
             more than 6 weeks of steroid use within 12 months of surgery, other than episodic use&#xD;
             or inhaled corticosteroids)&#xD;
&#xD;
          -  Subject has severe osteopenia, osteoporosis, osteomalacia, spinal metastases, or&#xD;
             metabolic bone disease that would significantly inhibit bone healing OR the level of&#xD;
             BMD is a T score of -2.5 or below OR patient has sustained a vertebral compression or&#xD;
             nontraumatic hip or wrist fracture.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hazem Eltahawy, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wayne State University, DMC</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Erica J Harris, MS</last_name>
    <phone>313-966-7218</phone>
    <email>eharri@med.wayne.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Diana Scanlon, RN, NP</last_name>
    <phone>313-745-7131</phone>
    <email>dscanlon@med.wayne.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Wayne State University</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erica J Harris, MS</last_name>
      <phone>313-966-7218</phone>
      <email>eharri@med.wayne.edu</email>
    </contact>
    <contact_backup>
      <last_name>Diana Scanlon, RN, NP</last_name>
      <phone>313-745-7131</phone>
      <email>dscanlon@med.wayne.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Hazem Eltahawy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <study_first_submitted>November 1, 2013</study_first_submitted>
  <study_first_submitted_qc>December 3, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 9, 2013</study_first_posted>
  <last_update_submitted>December 3, 2013</last_update_submitted>
  <last_update_submitted_qc>December 3, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 9, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Wayne State University</investigator_affiliation>
    <investigator_full_name>Hazem Eltahawy MD</investigator_full_name>
    <investigator_title>Assistant Professor, Neurosurgeon</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spondylosis</mesh_term>
    <mesh_term>Spinal Cord Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

